To test the biological significance of high ZEB1 expression in conferring resistance to gefitinib in EGFR‐mutant NSCLC cells in vivo, PC9‐ZEB1 and PC9‐mock cells were implanted subcutaneously in NOG mice. The gene discussed is ZEB1; the disease is non-small cell lung carcinoma.